Devices › Device types
FDA product code JHI · class 2 · Clinical Chemistry
Visual, pregnancy hcg, prescription use: medical device reports filed with FDA
3,859 reports carry this product code, 1996–2026; 11 brands with a page.
- 3,859
- reports with this product code
- 0% of all MAUDE reports
- 218
- reports, 12 months to August 2026
- 292 in the 12 months before
- 86.3%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code JHI is FDA's classification for "Visual, pregnancy hcg, prescription use" (clinical Chemistry panel), a class 2 device. 3,859 medical device reports carry this product code, 0% of the MAUDE database, from July 1996 to August 2026.
218 reports arrived in the 12 months to August 2026, down 25% from 292 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (86.3%), other (8.2%) and injury (5.1%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Axsym Total Bhcg | 268 | 0 | 0% | 68.8% |
| Consult Hcg Urine Cassette 5001 25t | 152 | 0 | 0% | 94.1% |
| Clinitek Status+ | 48 | 25 | 0% | 83.7% |
| Architect I2000sr Analyzer | 25 | 0 | 0.1% | 95.2% |
| Abbott Axsym System | 14 | 0 | 0% | 54.4% |
| Dimension | 10 | 40 | 0.1% | 98.5% |
| Synchron Lx I 725 Clinical System | 5 | 0 | 0% | 73.1% |
| Access Immunoassay System | 2 | 0 | 0% | 31% |
| Architect I2000 Analyzer | 2 | 0 | 0% | 91.5% |
| Cobas 6000 E 601 Module | 2 | 0 | 0% | 99.7% |
| Vitros Eci Immunodiagnostic System | 1 | 0 | 0% | 99.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Alere San Diego | 2,373 | 61.5% |
| Beckman Coulter | 202 | 5.2% |
| Biosite | 159 | 4.1% |
| Siemens Healthcare Diagnostics | 159 | 4.1% |
| Abbott Manufacturing | 60 | 1.6% |
| Biomerieux | 10 | 0.3% |
| Dade Behring | 10 | 0.3% |
| Abbott Laboratories | 8 | 0.2% |
| Ortho-Clinical Diagnostics | 8 | 0.2% |
| Quidel | 4 | 0.1% |
| Tosoh | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| False negative result | 1,668 | 43.2% |
| False positive result | 1,384 | 35.9% |
| Incorrect, inadequate or imprecise result or readings | 379 | 9.8% |
| Incorrect or inadequate test results | 246 | 6.4% |
| High test results | 83 | 2.2% |
| Low test results | 57 | 1.5% |
| Device displays incorrect message | 39 | 1% |
| Insufficient device problem information | 12 | 0.3% |
| Contamination | 11 | 0.3% |
| Improper or incorrect procedure or method | 10 | 0.3% |
| False reading from device non-compliance | 8 | 0.2% |
| Method, improper/incorrect | 8 | 0.2% |
| Non reproducible results | 6 | 0.2% |
| Unable to obtain readings | 6 | 0.2% |
| High readingsreadings were too high | 5 | 0.1% |
| Low readingsreadings were too low | 5 | 0.1% |
| Product quality problem | 4 | 0.1% |
| Replace | 4 | 0.1% |
| Calibration error | 3 | 0.1% |
| Device issuea problem with the device | 3 | 0.1% |
Questions about visual, pregnancy hcg, prescription use reports
What is product code JHI?
FDA's classification code for "Visual, pregnancy hcg, prescription use", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,859 reports through August 2026, 218 of them in the latest 12 months.
Which brands appear most often?
Axsym Total Bhcg (268), Consult Hcg Urine Cassette 5001 25t (152), Clinitek Status+ (48), Architect I2000sr Analyzer (25) and Abbott Axsym System (14). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.